Helen Lillistone
Corporate Officer/Principal chez VELOCYS
Profil
Helen Alice Lillistone is currently the Director at Shire Holdings Europe Ltd., Director at NPS Pharma UK Ltd., and Head-Global Finance & Information Technology at Velocys Plc.
Previously, she worked as a Director at Viropharma Ltd.
and Head-European Finance Operations at Shire Plc.
She completed her undergraduate degree at Southampton Business School.
Postes actifs de Helen Lillistone
| Sociétés | Poste | Début |
|---|---|---|
| VELOCYS | Corporate Officer/Principal | - |
Shire Holdings Europe Ltd.
 Shire Holdings Europe Ltd. Financial ConglomeratesFinance Founded in 1996, Shire Holdings Europe Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding British company. The private company is based in London, UK. | Director/Board Member | 24/03/2016 |
NPS Pharma UK Ltd.
 NPS Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., NPS Pharma UK Ltd. is a private company that develops and markets medicines for patients with rare diseases. The company is based in London, UK and was founded in 2006. | Director/Board Member | 24/03/2016 |
Anciens postes connus de Helen Lillistone
| Sociétés | Poste | Fin |
|---|---|---|
Viropharma Ltd.
 Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom. | Director/Board Member | 31/12/2018 |
| SHIRE | Corporate Officer/Principal | - |
Formation de Helen Lillistone
| Southampton Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VELOCYS | Producer Manufacturing |
| Entreprise privées | 4 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Holdings Europe Ltd.
Shire Holdings Europe Ltd. Financial ConglomeratesFinance Founded in 1996, Shire Holdings Europe Ltd. is a subsidiary of Takeda Pharmaceutical Co., Ltd. and functions as an investment holding British company. The private company is based in London, UK. | Finance |
Viropharma Ltd.
Viropharma Ltd. Pharmaceuticals: MajorHealth Technology Viropharma Ltd. manufactures pharmaceutical products. The company was founded on May 14, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
NPS Pharma UK Ltd.
NPS Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., NPS Pharma UK Ltd. is a private company that develops and markets medicines for patients with rare diseases. The company is based in London, UK and was founded in 2006. | Health Technology |
